Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers

Clinical trial NCT06135896 · RECRUITING

Trial details

NCT number: NCT06135896
Sponsor: National Cancer Center, Korea
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Pancreatic Cancer Unresectable Bile Duct Carcinoma Unresectable Biliary Tract Carcinoma

Start date: 2024-01-16
Primary completion: 2026-06-30
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.